Previous Close | 0.0004 |
Open | 0.0004 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.0004 - 0.0004 |
52 Week Range | 0.0001 - 0.0004 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | -0.59 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.8470 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for HULK
Pontus Protein Ltd. (TSXV: HULK) (OTCQB: HLKKF) (FSE: 8YC) ("Pontus" or the "Company") announces that the Company's principal regulator, the British Columbia Securities Commission (the "BCSC") has issued a Cease Trade Order (the "CTO") as a result of the Company's failure to file its audited annual financial statements for the year ended December 31, 2021, the related management's discussion and analysis and officer certifications (collectively, the "Annual Filings") by March 30, 2022, being the
Pontus Protein Ltd. (TSXV: HULK) (OTCQB: HLKKF) (FSE: 8YC) ("Pontus" or the "Company") is pleased to announce the appointment of Mr. Avtar Dhaliwal as Chief Executive Officer and Mr. Mohsen Rahimi to the board as an independent board member, replacing Mr. Connor Yuen who will be moving to the position of founder. In his role as founder, Mr. Yuen will continue to work with the company on key business development initiatives and help transition the leadership while Mr Dhaliwal will be responsible